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Abstract 
Objective. This study was to compare pregnancy outcomes between cerclage and expectant 
management in wemen with a dilated cervix. Design. Retrospective multicenter cohort 
study. Setting. Five hospitals of Catholic University Medical Center Network in Korea. 
Population. A total of 173 women between 14 0/7 and 29 6/7 weeks’ gestation with cervical 
dilation of 1 cm or greater by digital examination. Methods. Pregnancy outcomes were 
compared according to cerclage or expectant management, with the use of propensity-score 
matching. Main Outcome Measures. Primary outcome was time from presentation until 
delivery (weeks). Secondary outcomes were gestational age at delivery, neonatal survival, 
morbidity, preterm birth, and so on. 
Results. Of 173 women, 116 received a cerclage (cerclage group), and 57 were managed 
expectantly without cerclage (expectant group). Cervical dilation at presentation, and the use 
of amniocentesis performed to exclude subclinical chorioamnionitis differed between two 
groups. In the overall matched cohort, there was significant difference in the time from 
presentation until delivery (cerclage vs. expectant group, 10.6±6.2 vs. 2.9±3.2 weeks, p 
<0.0001). While there was no significant difference in the neonatal survival between two 
groups, there werelower neonatal morbidity as well as higher pregnancy maintenance rate at 
28, 32, 34 and 37 weeks’ gestation in the cerclage group, compared with the expectant group. 
Conclusion.  This  study  suggests  that  digital  examination–indicated  cerclage  appears  to 
prolong gestation and decrease neonatal morbidity, compared with expectant management in 
women with cervical dilation between 14 0/7 and 29 6/7 weeks. 
Key words: Cerclage, Cervical dilation, Preterm birth 
Introduction 
Preterm birth and its consequences constitute a 
major health problem in the worldwide. Many pre-
ventative  strategies  have  been  tried,  including  pro-
gesterone  supplementation,  antibiotic  usage,  to-
colytics and cervical cerclage, but the incidence has 
not reduced (1). 
Physical  or  digital  examination–indicated  cer-
clage, deﬁned as a cerclage placed because of cervical 
dilation, regardless of cervical length, obstetric histo-
ry,  or  risk  factors  for  preterm  birth,  has  been  sug-
gested as a therapy for these women. There is no in-
tervention proven to prevent preterm birth in women 
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with second-trimester cervical dilation. Indomethacin 
therapy in women with dilated cervix at 14 0/7 to 25 
6/7 weeks, regardless of cerclage or not, had no effect 
on pregnancy outcomes (2). Cerclage in women with 
cervical  dilation  has  been  studied  in  only  one  ran-
domized trial of 23 women, including both singleton 
and twin gestations (3). Women with cervical dilation 
at preterm have been shown to have high rates of in-
flammation  and  possibly  of  contractions.  Recently, 
one large cohort study reported that physical exami-
nation–indicated  cerclage  appears  to  prolong  gesta-
tion and improve neonatal survival, compared with 
expectant management in selected women with cer-
vical dilation between 14 0/7 and 25 6/7 weeks (4).  
It has been demonstrated that the rates of neo-
natal  mortality  and  complications  are  significant  in 
preterm  babies  born  prior  to  32  weeks  of  gestation 
and with body weight less than 1,500 g (5,6). The in-
cidence of perinatal death has been considerably de-
creased as the neonatology has been making its ad-
vance, but it is still a critical issue to manage morbid-
ity and mortality after preterm delivery. Gestational 
age can be one of the most important predictors of 
morbidity  and  mortality  of  neonates.  Whereas  the 
group of infants with the greatest risk of morbidity 
and  mortality  comprises  those  born  at  less  than  32 
weeks of gestation, infants born between 32 and 36 
weeks represent the greatest number of infants born 
preterm (7). The latter group of infants also experi-
ences  a  greater  risk  for  health  and  developmental 
problems compared with the risk for infants born at 
term(7). It is clear that the rates of infant survival and 
of being born as normal infants are high as gestational 
age approaches close to the full term. There is need to 
investigate the value of cerclage including the women 
with  cervical  dilation  between  26  0/7  and  29  6/7 
weeks. 
The objectives of our study was to estimate fetal 
and maternal outcomes associated with physical ex-
amination–indicated  cerclage,  compared  with  ex-
pectant management in women with cervical dilation 
between 14 0/7 and 29 6/7 weeks’ gestation. 
Methods 
This is a retrospective cohort study of the women 
with  cervical  dilation  between  14  0/7  and  29  6/7 
weeks’  gestation  who  received  expectant  manage-
ment  or  digital-examination  indicated  cerclage,  be-
tween  January  2000  and  June  2010  at  5  centers  in 
Catholic  University  Medical  Center  of  Korea.  Ap-
proval by the institutional review board was obtained 
at each participating center. Participating centers were 
all  university  teaching  or  tertiary  care  centers  with 
neonatal intensive care units with the ability to ad-
minister  surfactant  and  vasopressors  and  provide 
ventilator support to neonates. Primary outcome was 
time  from  presentation  until  delivery  (weeks).  Sec-
ondary  outcomes  were  gestational  age  at  delivery, 
neonatal  survival,  significant  neonatal  morbidity, 
preterm birth less than 28, 32, 34, 37 weeks, and birth 
weight less than 1500g. Significant neonatal morbidity 
included  respiratory  distress  syndrome  requiring 
surfactant, sepsis, intracranial hemorrhage, necrotiz-
ing enterocolitis, and bronchopulmonary dysplasia. 
Inclusion criteria 
The women followed up in this study were ini-
tially identiﬁed in 1 of 2 ways: 1) those found to have a 
shortened  cervix  or  suspected  cervical  dilation  on 
ultrasound or 2) those identiﬁed by digital examina-
tion performed because of a history of prior second 
trimester loss, history of preterm birth, or subjective 
complaints of pressure or discharge. The subjects with 
cervical dilatation of 1 cm or greater by digital exam-
ination between 14 0/7 and 29 6/7 weeks’ gestation 
were included.  
Exclusion criteria 
Subjects  with  preterm  premature  rupture  of 
membranes (PPROM), active labor, vaginal bleeding, 
or chorioamnionitis at time of presentation and those 
with a closed cervix on digital examination were ex-
cluded. PPROM was deﬁned by gross rupture of am-
niotic  ﬂuid  with  oligohydramnios  or  anhydramnios 
on ultrasound, or visualizing amniotic ﬂuid collection 
on sterile speculum exam, with the presence of a Ni-
trazine positive vaginal pool of ﬂuid. Active labor was 
deﬁned as the presence of regular uterine contractions 
3 or more in 10 minutes with cervical change. Chori-
oamnionitis was deﬁned by the following: 1) positive 
amniotic ﬂuid culture (aerobic and anaerobic bacteria, 
ureaplasma, or mycoplasma);  2) the combination of 
positive  amniotic  ﬂuid  Gram  stain,  amniotic  ﬂuid 
leukocyte  count  greater  than  50  cells/mm3,  and/or 
amniotic ﬂuid glucose 14 mg/dL or less; 3) interleu-
kin-6 greater than 2 ng/mL at centers at which this 
test was available; or 4) clinical chorioamnionitis as 
deﬁned by Gibbs et al (8). 
Subjects were not randomly assigned to a par-
ticular  management  strategy.  Clinical  management 
was  made  case  by  case  between  the  physician  and 
patient after an informed discussion. Physical exami-
nation–indicated cerclage was available at all centers 
participating in this study.  
Mcdonald Cerclage was performed under spinal 
anesthetic  in  a  ‘head  down’  position,  using  a 
Mersilene tape (Ethicon, Inc, Somerville, NJ). A Foley 
catheter  or  sponge  forceps  was  used  to  replace  the Int. J. Med. Sci. 2011, 8 
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membranes  through  the  cervix  if  the  membrane  is 
protruded  through  the  cervical  canal  or  visible  be-
yond the external oriﬁce of the uterus. Management 
thereafter involved bed rest or nifedipine or sympa-
thomimetics, antibiotics on an individual basis.  The 
sutures  were  removed  in  all  women  who  labored, 
ruptured their membranes and developed clear evi-
dence of infection or on reaching 37 weeks’ gestation. 
After application of the inclusion and exclusion 
criteria as described, 173 women of the 308 women 
with dilated cervix were  included in this investiga-
tion. Thereof 116 received operative (Cerclage group) 
and 57 expectant treatment (Expectant group). 
Statistical Analysis 
For  observed  cohort  data,  comparison  of  cate-
gorical variables was used by χ2 test, whereas inde-
pendent t-test was used to compare continuous vari-
ables. 
To reduce the effect of treatment-selection bias 
and  potential  confounding  in  this  observational 
study, we performed rigorous adjustment for signifi-
cant differences in the prognostic factors such as ges-
tational age at diagnosis, cervical dilation at diagno-
sis,  previous  cervical  incompetence,  and  amniocen-
tesis  performed  to  exclude  subclinical  chorioamni-
onitis which were significantly or marginally signifi-
cantly different between two groups with the use of 
propensity-score matching (9, 10).  
After  all  the  propensity-score  matches  were 
performed, we compared the baseline covariates be-
tween two groups. Continuous variables were com-
pared with the use of the mixed model analysis and 
categorical variables were compared with the use of 
Generalized  estimating  equations  (GEE)  analysis. 
GEE  analysis  was  also  used  to  obtain  the  matched 
odds ratio and its 95% confidence interval. 
Survival curves were obtained by Kaplan–Meier 
estimates and compared by of Cox regression models 
with  robust  standard  errors  that  accounted  for  the 
clustering of matched pairs (11, 12). 
All reported p values are two-sided, and p val-
ues of less than 0.05 were considered to indicate sta-
tistical  significance.  SAS  software,  version  9.1was 
used for statistical analyses. 
Details of ethics approval  
Ethical  approval  was  granted  by  the  Catholic 
Medical  Center,  Central  Ethics  Board 
(XC11RIMI0002K) at Jan 14, 2011. 
Results 
A total of 308 women between 14 0/7 and 29 6/7 
weeks’ gestation with suspected cervical dilation 1 cm 
or greater were identiﬁed, during the study perioid. 
Of these 308 women, 7 were excluded because of cer-
vical dilation less than 1 cm. An additional 69 were 
found to have contraindications to cerclage (Figure 1). 
Of the 232 remaining subjects, 6 wanted for induction 
of labor or surgical termination. 
These patients were followed up for the devel-
opment of any maternal complications but were ex-
cluded  from  this  analysis.  Women  with  multifetal 
gestations were excluded (13 twins, 1 triplet), and of 
the remaining 212 singletons, outcomes were availa-
ble in 81.6% (28 women in the cerclage group and 11 
women  in  the  expectant  group  were  lost  to  fol-
low-up), leaving 173 women in the ﬁnal cohort. Sta-
tistical analysis was conducted on these 173 women, 
57 who were managed without cerclage and 116 who 
underwent  cerclage  placement  at  the  obstetrician’s 
discretion. 
There were no statistical difference in mean ages, 
parities, and gestational age at presentation with sim-
ilar rates of prior preterm birth and abortion, between 
cerclage  group  and  expectant  group  (Table  1).  Alt-
hough women receiving cerclage seemed more likely 
to have had a previous second-trimester miscarriage, 
there was no statistical difference. Mean cervical dila-
tion of subjects undergoing cerclage was less than in 
expectant  group  (p  <  0.0001);  however,  the  use  of 
amniocentsis performed to exclude subclinical chori-
oamnionitis was lower in the group receiving cerclage 
(p=0.0293). Gestational weeks at diagnosis and history 
of  previous  cervical  incompetence  were  marginally 
significantly different between two groups (p=0.051 
and p=0.0555, respectively). The incidence of antena-
tal steroid administration did not differ.  
Table 1. Baseline Characteristics of the observed cohort 
  Cerclage 
group 
 (N=116) 
Expectant 
group 
(N=57) 
P-value 
Age*  31.42±3.82  30.86±4.79  0.4409 
Parity*  0.99±1.04  0.98±0.88  0.9557 
Previous preterm birth*  0.32±0.49  0.39±0.56  0.419 
Previous abortion*  0.78±1.03  1.07±1.57  0.2095 
Gestational week at diagnosis*  22.42±4.14  23.51±3.04  0.051 
Cervical dilatation at diagno-
sis* 
1.99±1.22  3.35±1.71  <0.0001 
Previous cervical incompe-
tence* 
0.16±0.45  0.3±0.50  0.0555 
Amniocentesis performed to 
exclude subclinical chorioam-
nionitis** 
27(23.3)  22(39.3)  0.0293 
Antenatal steroids adminis-
tered** 
46(39.7)  25(44.7)  0.5336 
Gestational week at delivery*  33.12±5.80  25.47±4.76  <0.0001 
* independent t test ** Chi-square test 
Values are expressed as mean±SD or n (%). Int. J. Med. Sci. 2011, 8 
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Figure 1. Flow diagram of all identiﬁed women between 14 0/7-29 6/7 weeks 
 
 
Characteristics of Patients Matched for Pro-
pensity Scores 
After propensity-score matching was performed 
for the entire population, there were 20 (2:1) matched 
pairs of 40 patients who received cerclage and 20 pa-
tients who received conservative care.  
In the matched cohorts, there was no longer any 
significant difference between the cerclage group and 
the  expectant  group  for  any  covariate,  especially, 
gestational  week  and  cervical  dilation  at  diagnosis, 
history of previous cervical incompetence, and the use 
of  amniocentesis  performed  to  exclude  subclinical 
chorioamnionitis,  which  were  significantly  or  mar-
ginally significantly different before propensity score 
matching (Table 2). 
Outcomes for the Matched Cohort 
Table 3 shows the clinical outcomes according to 
the treatment approach in the overall matched cohort. 
The  analysis  of  the  primary  outcome  showed  a 
signiﬁcant increase in pregnancy prolongation (mean 
10.6 vs. 2.9 weeks, P < 0.0001) and gestational age at 
delivery (mean 33.7 vs. 27.2 weeks, P < 0.0001) in the 
cerclage group, compared with the expectant group.  Int. J. Med. Sci. 2011, 8 
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Birth weight, Apgar score, preterm birth at less 
than 28, 32, 34, and 37 weeks, and birth weight less 
than 1500 and 2000g were all improved by clinical-
ly-indicated cerclage. 65% (13 of 20) of women who 
were  expectantly  managed  delivered  prior  to  28 
weeks, compared with 20% (8 of 40) of women who 
received a cerclage. Also, 95% (19 of 20) and 100% (20 
of 20) of women who were expectantly managed de-
livered  prior  to  34  weeks  and  37  weeks,  compared 
with 47.5% (19 of 40) and 65% (26 of 40) women who 
received a cerclage (Table 3 and Figure 2). While the 
analysis  for  the  neonatal  survival  failed  to  demon-
strate  a  difference  (85.0%  vs.  60.0%,  P=0.0923),  it 
demonstrated  a  difference  in  the  rate  of  significant 
neonatal  morbidity  (37.5%  vs.  80.0%,  P=0.0036)  be-
tween  the  cerclage  and  expectant  groups.  The  pro-
portion of pregnancy maintenance until 37 weeks was 
significantly higher in cerclage group (p< 0.001) (Fig-
ure 2). 
Significant neonatal morbidity decreased to 0.15 
fold in the cerclage group, compared to the expectant 
group. The use of digital examination–indicated cer-
clage was associated with a greater than 3-, 10-, and 
21-fold increase in birth after 28, 32, and 34 weeks, 
respectively, as well as 9- and 10-fold increase in birth 
weight greater than 1500 and 2000g (Table 4). 
 
 
Table 2. Baseline Characteristics of the Propensi-
ty-Matched Patients 
  Cerclage 
group 
(N=40) 
Expectant 
group 
(N=20) 
P-value 
Age*  31.95±4.33  32.25±5.26  0.8067 
Parity*  1.00±0.96  0.90±0.97  0.7285 
Previous preterm birth*  0.33±0.47  0.30±0.57  0.8578 
Previous abortion*  0.62±0.85  0.95±1.03  0.1404 
Gestational week at diagno-
sis* 
23.05±3.95  24.29±2.59  0.1296 
Cervical dilatation at diag-
nosis* 
1.83±0.87  1.75±0.79  0.4982 
Previous cervical incompe-
tence* 
0.13±0.33  0.05±0.22  0.3492 
Amniocentesis performed to 
exclude subclinical chori-
oamnionitis** 
6(15.0)  3(15.0)  1.0000 
Antenatal steroids adminis-
tered** 
19(47.5)  14(70.0)  0.1282 
* Mixed model analysis ** GEE analysis 
Values are expressed as mean±SD or n (%). 
 
Table 3. Pregancy outcomes of the Propensity-Matched 
Patients. 
  Cerclage 
group 
(N=40) 
Expectant 
group 
(N=20) 
P-value 
Interval from presentation to 
delivery (weeks) * 
10.64±6.22  2.94±3.21  <0.0001 
Gestational week at delivery*  33.70±5.35  27.23±4.42  <0.0001 
Birth weight (g) *  2203±987.69  1112±611.87  <0.0001 
Apgar score at 1 minute*  6.13±2.85  3.35±2.58  0.0012 
Apgar score at 5 minutes*  7.23±3.05  4.55±3.07  0.0049 
Preterm birth less than 28 
weeks** 
8(20.0)  13(65.0)  <0.0001 
Preterm birth less than 32 
weeks** 
14(35.0)  17(85.0)  0.0018 
Preterm birth less than 34 
weeks** 
19(47.5)  19(95.0)  0.0046 
Preterm birth less than 37 
weeks** 
26(65.0)  20(100.0)  <0.0001 
Birthweight less than 1500g**  10(25.0)  15(75.0)  0.0002 
Birthweight less than 2000g**  19(47.5)  18(90.0)  0.004 
Neonatal survival**  34(85.0)  12(60.0)  0.0923 
Significant neonatal morbid-
ity** 
15(37.5)  16(80.0)  0.0036 
* Mixed model analysis ** GEE analysis 
Values are expressed as mean±SD or n (%). 
Significant neonatal morbidity: respiratory distress syndrome 
which needs administration of surfactant, sepsis, intracranial hem-
orrhage, necrotizing enterocolities, and bronchopulmonary dys-
plasia. 
 
 
 
Table 4. Efficacy of clinically indicated cerclage on neonatal 
outcomes in the propensity matched patients.  
Neonatal outcomes  OR*  95% CI 
Neonatal survival  3.19  0.83-12.3 
Significant neonatal morbidity  0.15  0.04-0.54 
Birth weight greater than 1500g  9  2.80-28.96 
Birth weight greater than 2000g  9.95  2.08-47.51 
Preterm birth more than 28 weeks  7.43  2.72-20.26 
Preterm birth more than 32 weeks  10.52  2.40-46.14 
Preterm birth more than 34 weeks  21  2.56-172.30 
OR, odds ratio; CI, conﬁdence interval, obtained by GEE analysis 
* Expectant management group is the reference group for all mod-
els. 
Significant neonatal morbidity: respiratory distress syndrome 
which needs administration of surfactant, sepsis, intracranial hem-
orrhage, necrotizing enterocolitis, and bronchopulmonary dyspla-
sia. 
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Figure 2. Kaplan–Meier curves for pregnancy maintenance in propensity matched patients who underwent cerclage or 
expectant management. Propensity matching for the entire cohort created 20 (2:1) matched pairs of patients. Survival curves 
show the gestational weeks without delivery following cerclage or expectant management (p < 0.001). 
 
 
Discussion 
Infants born preterm are at greater risk than in-
fants born at term for mortality and a variety of health 
and developmental problems. The birth of a preterm 
infant  can  also  bring  considerable  emotional  and 
economic costs to families and have implications for 
public-sector services, such as health insurance, edu-
cational, and other social support systems. 
The  current  methods  for  the  diagnosis  and 
treatment of preterm labor are currently based on an 
inadequate literature, and little is known about how 
preterm birth can be prevented. Treatment has been 
focused  on  inhibiting  contractions.  This  has  not  re-
duced the incidence of preterm birth but has delayed 
delivery long enough to allow the administration of 
antenatal steroids and transfer of the mother and fetus 
to a hospital where they may receive appropriate care. 
These interventions have reduced the rates of perina-
tal mortality and morbidity. Although improvements 
in perinatal and neonatal care have significantly im-
proved the rates of survival for infants born preterm, 
these infants remain at risk for a host of acute and 
chronic health problems.  
Therapies  and  interventions  for  the  prediction 
and the prevention of preterm birth are thus needed. 
The  management  of  a  patient  with  se-
cond-trimester  cervical  dilation  continues  to  pose  a 
difﬁcult dilemma for obstetricians. Management op-
tions considered include expectant management, cer-
vical cerclage, and pregnancy termination via induc-
tion of labor or dilation and evacuation. In one large 
randomized clinical trial, the cerclage in women with 
a  short  cervix  identified  by  routine  sonographic 
screening  at  midtrimester  has  not  substantially  re-
duced the risk of preterm delivery (13). However, the 
women with cervical dilation were excluded in this 
trial. Based on the previous reports, it seems that cer-
clage  placement  does  not  improve  pregnancy  out-
come in low-risk women with incidental detection of 
short cervix in the early second trimester (14,15). 
However, when a physician identifies a dilated 
cervix by digital examination in high risk women, or 
in women with short cervix by transvaginal ultraso-
nography, there is still lack of evidence about cerclage 
or expectant management. Only one small  random-
ized controlled trial of women with cervical dilation 
have all reported a reduction in preterm birth associ-Int. J. Med. Sci. 2011, 8 
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ated  with  cerclage  in  women  with  a  dilated  cervix 
when compared with bed rest (3). Recent retrospec-
tive cohort studies support that the physical exami-
nation–indicated cerclage has shown some benefits in 
selected women with cervical dilation less than 26 0/7 
weeks (4, 16-18). In these previous studies, all women 
at all institutions were not screened for cervical dila-
tion.  Instead,  women  with  cervical  dilation  were 
identiﬁed  in  1  of  2  ways:  1)  those  found  to  have  a 
shortened  cervix  or  suspected  cervical  dilation  on 
ultrasound or 2) those identiﬁed by screening digital 
examination performed because of a history of prior 
second-trimester  loss,  history  of  preterm  birth,  or 
subjective  complaints  of  pressure  or  discharge.  We 
identified  candidate  women  with  same  methods. 
However, we included women with cervical dilation 
between 140/7 and 296/7 weeks’ gestation. 
The greatest risk of mortality and morbidity is 
for those infants born at the earliest gestational ages. 
However, those infants born nearer to term represent 
the greatest number of infants born preterm and also 
experience  more  complications  than  infants  born  at 
term. Even late preterm births (34 0/7-36 6/7 weeks), 
compared with term delivery, have been reported that 
it is associated with increased risk of respiratory dis-
tress syndrome and other respiratory morbidity (19). 
Other  recent  reports  also  demonstrated  that  late 
prematurity  is  associated  with  significant  neonatal 
morbidity such as respiratory distress syndrome, in-
traventricular  hemorrhage,  and  sepsis  in  cases  of 
spontaneous low-risk singleton deliveries (20, 21). In 
our study, the average weeks of pregnancy prolonga-
tion in the expectant group was just 2.9 weeks, com-
pared  to  10.6  weeks  in  the  cerclage  group.  Even 
though there was no difference in neonatal survival 
between two groups, significant neonatal morbidities 
were much less in the cerclage group. It might be a 
reason that 95% and 100% of women who were ex-
pectantly  managed,  compared  with  47.5%  and  65% 
women who received a cerclage, delivered prior to 34 
weeks and 37 weeks.  
Our study has several limitations. We evaluated 
observational data, and therefore the treatment strat-
egy was not based on randomized assignment. The 
choice of cerclage was at the discretion of the treating 
physician or the patient. We acknowledge, however, 
that the particulars of clinical practice in the hospitals 
in this trial, as well as the specific experts in maternal 
fetal medicine who  performed the procedures, may 
differ from those of other institutions and practition-
ers,  potentially  limiting  the  reproducibility  of  these 
results  in  other  settings.  The  retrospective  nature 
opens these data to bias. To minimize these biases, we 
used  propensity-score  matching,  even  though  our 
sample size was decreased after the matching (9, 10). 
Previous research has suggested that matching 
according to the propensity score eliminates a greater 
proportion  of  baseline  differences  between  two 
treatments  than  does  stratification  or  covariate  ad-
justment (22). Given these issues and the findings of 
our study, we believe that a randomized trial of digi-
tal  examination–indicated  as  compared  with  ex-
pectant management is warranted in patients between 
14 0/7 and 29 6/7 weeks’ gestation with painless cer-
vical dilation between 1 and 4 cm.  
In conclusion, this study supports digital exam-
ination–indicated  cerclage  in  women  who  found  to 
have a shortened cervix or suspected cervical dilation 
on  ultrasound  or  who  was  identiﬁed  by  screening 
digital examination performed because of a history of 
prior second-trimester loss, history of preterm birth, 
or  subjective  complaints  of  pressure  or  discharge, 
between  14  0/7  and  29  6/7  weeks’  gestation  with 
painless cervical dilation between 1 and 4 cm, before 
the  result  of  randomized  trial  is  available.  Even 
though  we  could  not  observe  the  significant  im-
provement in neonatal survival, we found significant 
improvement in neonatal morbidity. It digital exam-
ination–indicated cerclage appears to prolong gesta-
tion, which might decrease significant neonatal mor-
bidities. 
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